Lamb Weston stock rating reiterated at Hold by Stifel with $61 target

Investing.comMonday, September 29, 2025 at 11:59:14 AM
Lamb Weston stock rating reiterated at Hold by Stifel with $61 target
Lamb Weston has received a stock rating of 'Hold' from Stifel, with a target price set at $61. This rating indicates that while the stock is not expected to decline significantly, it may not see substantial growth in the near term either. Investors should consider this cautious outlook as they evaluate their options in the food industry.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Carnival stock holds Buy rating at Stifel on strong 2026 booking trends
PositiveFinancial Markets
Carnival's stock has received a Buy rating from Stifel, reflecting strong booking trends for 2026. This positive outlook is significant as it indicates confidence in the company's recovery and growth potential in the cruise industry, which has faced challenges in recent years. Investors may find this news encouraging as it suggests a rebound in consumer interest and travel plans.
Stifel maintains Hold rating on Waters stock amid BD acquisition plans
NeutralFinancial Markets
Stifel has decided to maintain its Hold rating on Waters Corporation's stock, even as the company plans to pursue acquisitions related to BD. This decision reflects a cautious approach to the potential impacts of these acquisitions on Waters' financial performance. Investors will be watching closely to see how these strategic moves unfold and what they mean for the company's future.
Cytokinetics stock maintains Buy rating at Stifel on promising aficamten data
PositiveFinancial Markets
Cytokinetics has received a Buy rating from Stifel, thanks to promising data on its drug aficamten. This positive assessment highlights the potential of aficamten in treating heart conditions, which could significantly impact patient care and the company's market position. Investors are optimistic about the future as this development may lead to increased stock value and greater interest in Cytokinetics' innovative therapies.
Birkenstock stock rating reiterated at Buy by Stifel on strong growth
PositiveFinancial Markets
Birkenstock's stock has received a Buy rating from Stifel, highlighting the company's strong growth potential. This endorsement is significant as it reflects confidence in Birkenstock's market position and future performance, which could attract more investors and boost the brand's visibility in the competitive footwear industry.
Stifel reaffirms Buy rating on Outset Medical stock at $17 price target
PositiveFinancial Markets
Stifel has reaffirmed its Buy rating on Outset Medical's stock, setting a price target of $17. This is significant as it reflects confidence in Outset Medical's growth potential and market position, which could attract more investors and positively impact the company's stock performance.
Starbucks stock holds Buy rating at Stifel amid $1 billion restructuring plan
PositiveFinancial Markets
Starbucks has received a 'Buy' rating from Stifel, which is particularly encouraging as the company embarks on a $1 billion restructuring plan. This move is significant as it reflects confidence in Starbucks' ability to adapt and thrive in a competitive market. Investors are likely to view this positively, as it suggests potential for growth and improved performance in the future.
Latest from Financial Markets
Trump renews threat to impose 100% tariffs on non-US made movies
NegativeFinancial Markets
President Trump has reignited his threat to impose 100% tariffs on movies not made in the United States, claiming that the American film-making industry has been 'stolen' by foreign countries. This move could have significant implications for the film industry, potentially raising costs for consumers and affecting international collaborations.
Ormat Technologies stock hits 52-week high at 95.39 USD
PositiveFinancial Markets
Ormat Technologies has reached a significant milestone as its stock price hit a 52-week high of 95.39 USD. This achievement reflects the company's strong performance and investor confidence in its renewable energy solutions. As the demand for sustainable energy sources continues to grow, Ormat's success is a positive indicator for the industry and could attract more investors looking for opportunities in green technology.
Trump administration tightens export controls on Chinese companies
NegativeFinancial Markets
The Trump administration has implemented stricter export controls targeting Chinese companies, particularly affecting subsidiaries of entities that have been blacklisted by the US government. This move is significant as it reflects ongoing tensions between the US and China, impacting trade relations and potentially hindering the operations of affected companies. The tightening of these controls could lead to further economic repercussions and escalate the trade conflict.
Honeywell's West Lays Out Future Energy Needs
PositiveFinancial Markets
In a recent interview, Honeywell's Energy and Sustainability Solutions President & CEO Ken West emphasized the growing demand for energy, predicting that the world will require more power in the future. This insight is crucial as it highlights the need for innovative solutions and sustainable practices to meet increasing energy needs, making it a significant topic for businesses and policymakers alike.
Carnival Q3 2025 presentation slides: Record $2B profit and third guidance raise
PositiveFinancial Markets
Carnival Corporation has reported a record profit of $2 billion for the third quarter of 2025, marking a significant milestone for the cruise line industry. This impressive financial performance not only highlights the company's recovery post-pandemic but also reflects strong consumer demand for travel experiences. Additionally, Carnival raised its guidance for the upcoming quarters, indicating confidence in sustained growth. This news is crucial as it signals a robust rebound in tourism and could positively impact related sectors.
CorVel Corp stock hits 52-week low at $77.64
NegativeFinancial Markets
CorVel Corp's stock has reached a 52-week low, dropping to $77.64, which raises concerns among investors about the company's financial health and market performance. This decline could impact investor confidence and may lead to further scrutiny of CorVel's business strategies and future prospects.